Authors' Response to Young et al: Re Stage III Non-small Cell Lung Cancer Management in England

Madam — We would like to thank Young and colleagues [1] for their letter noting that data supplied to the National Cancer Registration and Analysis Service (NCRAS) and used in analyses by the National Lung Cancer Audit (NLCA) from their own institutions may not have been accurate. They question whether this problem may exist at a wider scale, potentially calling into question the results and conclusions of our recently published analysis of the management and outcome of stage III non-small cell lung cancer [2].

Source: Clinical Oncology - June 23, 2020 Category: Radiology Authors: S.V. Harden, J.B. Adizie, N. Navani, P. Beckett Tags: Letter Source Type: research